LU92747I2 - Virus de la diarrhée bovine atténué 1 (bvdv-1) - Google Patents

Virus de la diarrhée bovine atténué 1 (bvdv-1) Download PDF

Info

Publication number
LU92747I2
LU92747I2 LU92747C LU92747C LU92747I2 LU 92747 I2 LU92747 I2 LU 92747I2 LU 92747 C LU92747 C LU 92747C LU 92747 C LU92747 C LU 92747C LU 92747 I2 LU92747 I2 LU 92747I2
Authority
LU
Luxembourg
Prior art keywords
bvdv
diarrhea virus
bovine diarrhea
attenuated bovine
attenuated
Prior art date
Application number
LU92747C
Other languages
English (en)
French (fr)
Original Assignee
Boehringer Ingelheim Vetmedia Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92747(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedia Gmbh filed Critical Boehringer Ingelheim Vetmedia Gmbh
Publication of LU92747I2 publication Critical patent/LU92747I2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU92747C 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1) LU92747I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
LU92747I2 true LU92747I2 (fr) 2015-11-02

Family

ID=34967522

Family Applications (3)

Application Number Title Priority Date Filing Date
LU92749C LU92749I2 (fr) 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
LU92747C LU92747I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée bovine atténué 1 (bvdv-1)
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU92749C LU92749I2 (fr) 2004-05-19 2015-06-19 Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU92748C LU92748I2 (fr) 2004-05-19 2015-06-19 Virus de la diarrhée virale bovine atténué 2 (bvdv-2)

Country Status (25)

Country Link
EP (1) EP1751276B9 (zh)
JP (2) JP5006782B2 (zh)
KR (1) KR100908798B1 (zh)
CN (2) CN103352030B (zh)
AR (2) AR049176A1 (zh)
AT (1) ATE420949T1 (zh)
AU (1) AU2005243488B2 (zh)
BR (1) BRPI0510396B1 (zh)
CA (1) CA2561719C (zh)
CY (4) CY1109036T1 (zh)
DE (2) DE102004025452A1 (zh)
DK (1) DK1751276T5 (zh)
ES (1) ES2321210T3 (zh)
HU (2) HUS1500033I1 (zh)
LU (3) LU92749I2 (zh)
ME (1) ME01119B (zh)
MX (1) MXPA06013298A (zh)
NL (3) NL300744I2 (zh)
NZ (1) NZ552088A (zh)
PL (1) PL1751276T3 (zh)
PT (1) PT1751276E (zh)
RS (1) RS50753B9 (zh)
SI (1) SI1751276T1 (zh)
UY (1) UY28905A1 (zh)
WO (1) WO2005111201A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
WO2008034857A1 (en) 2006-09-22 2008-03-27 Intervet International B.V. Pestivirus mutant for use in a vaccine
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8815255B2 (en) 2008-10-31 2014-08-26 Boehringer Ingelheim Vetmedica, Inc. Use of Mycoplasma bovis antigen
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
EP2618841B1 (en) * 2010-09-21 2016-10-19 Intervet International B.V. Bvdv vaccine
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
ES2757927T3 (es) * 2014-05-23 2020-04-30 Boehringer Ingelheim Vetmedica Gmbh Virus de la peste porcina clásica (VPPC) recombinante que comprende sustituciones en el epítopo TAV de la proteína E2
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) * 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
NL300743I2 (zh) 2016-01-26
CN103352030B (zh) 2018-08-10
DK1751276T5 (da) 2020-07-20
HUS1500031I1 (hu) 2019-11-28
EP1751276A1 (en) 2007-02-14
KR20070012862A (ko) 2007-01-29
AR104448A2 (es) 2017-07-19
EP1751276B1 (en) 2009-01-14
DE102004025452A1 (de) 2006-01-19
RS50753B9 (sr) 2020-08-31
EP1751276B9 (en) 2020-05-27
JP2007537740A (ja) 2007-12-27
CA2561719A1 (en) 2005-11-24
CY2015023I2 (el) 2024-02-16
LU92749I2 (fr) 2015-11-02
CY1109036T1 (el) 2014-07-02
NL300745I1 (zh) 2016-01-26
JP2012061001A (ja) 2012-03-29
BRPI0510396B1 (pt) 2020-08-18
CA2561719C (en) 2015-01-27
ES2321210T3 (es) 2009-06-03
JP5006782B2 (ja) 2012-08-22
CY2015022I1 (el) 2020-05-29
KR100908798B1 (ko) 2009-07-22
UY28905A1 (es) 2005-12-30
NZ552088A (en) 2009-10-30
JP5562316B2 (ja) 2014-07-30
ME01119B (me) 2013-03-20
ES2321210T9 (es) 2020-11-04
DE602005012381D1 (de) 2009-03-05
BRPI0510396A (pt) 2007-11-13
CN1989240B (zh) 2013-07-31
PT1751276E (pt) 2009-02-24
ATE420949T1 (de) 2009-01-15
CY2015023I1 (el) 2020-05-29
AU2005243488A1 (en) 2005-11-24
NL300743I1 (zh) 2016-01-26
AU2005243488B2 (en) 2011-07-07
WO2005111201A1 (en) 2005-11-24
NL300744I1 (zh) 2016-01-26
CY2015021I1 (el) 2020-05-29
RS50753B (sr) 2010-08-31
SI1751276T1 (sl) 2009-06-30
CY2015021I2 (el) 2023-11-15
NL300744I2 (zh) 2016-01-26
HUS1500033I1 (hu) 2015-07-28
CY2015022I2 (el) 2024-02-16
MXPA06013298A (es) 2007-05-07
PL1751276T3 (pl) 2009-06-30
NL300745I2 (zh) 2016-01-26
CN103352030A (zh) 2013-10-16
LU92748I2 (fr) 2015-11-02
AR049176A1 (es) 2006-07-05
CN1989240A (zh) 2007-06-27
DK1751276T3 (da) 2009-05-18

Similar Documents

Publication Publication Date Title
LU92747I2 (fr) Virus de la diarrhée bovine atténué 1 (bvdv-1)
DE60325255D1 (de) Duftzusammensetzung
DE602004021120D1 (de) Photopolymerisierbare zusammensetzung.
DE60332977D1 (de) Endoprothese
DK1437106T3 (da) Prøveimplantatsæt
MX245044B (es) Composiciones de filtro solar.
FI20010694A0 (fi) Implantti
DE50112625D1 (de) Turbomaschine
DE60322340D1 (de) Riechstoffverbindung
DE50206249D1 (de) Turbomaschine
NO20041984L (no) Stenter
DE50100531D1 (de) Turbomaschine
DE60301188D1 (de) Schwingungsdämpfendes Verbindungsglied
ATE300179T1 (de) Biopestizid-zusammensetzungen
FI20020881A0 (fi) Iskulaite
DE60216645D1 (de) Antiulcus pflanzenzusammensetzung(en)
DE50301116D1 (de) 9-alpha-substituierte estratriene als selektiv wirksame estrogene
ATA6842001A (de) Tank
ITTO20020744A1 (it) Composizione.
DE50200573D1 (de) Prepreg
FR2851156B1 (fr) Prothese du genou.
DE50303730D1 (de) Weiche, insbesondere zum verzweigen von schüttgutströmen
DE50303406D1 (de) Elektromagnet
ITRM20010554A0 (it) Laringe artificiale.
ES1050301Y (es) Ambientador perfeccionado.